LogoEmail.png
Generex Biotechnology Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services
May 11, 2021 09:00 ET | Generex Biotechnology Corp.
NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population.Westside Medicine & Cardiology, Inc. is a professional...
LogoEmail.png
Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets
May 10, 2021 09:00 ET | Generex Biotechnology Corp.
Update on Ii-Key-SARS-CoV-2 vaccine programAppointment of Dr. Craig Eagle to be Chairman of the Board of NuGenerex Immuno-Oncology Inc. pending board approval.Re-Launch of Excellagen® in the VA...
LogoEmail.png
Generex Biotechnology Subsidiary NuGenHealth Contracts with Florida Health Care Associates to Provide Remote Patient Monitoring (RPM) Services
May 06, 2021 08:30 ET | Generex Biotechnology Corp.
NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population.Florida Health Care Associates is a professional...
LogoEmail.png
Generex Provides Clarification on Its Ii-Key COVID-19 Complete Vaccine China Partnership Agreement
May 05, 2021 12:20 ET | Generex Biotechnology Corp.
MIRAMAR, Fla., May 05, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company...
LogoEmail.png
Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Thursday May 6, 2021 at 9:00 AM
May 04, 2021 13:12 ET | Generex Biotechnology Corp.
MIRAMAR, Fla., May 04, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company...
LogoEmail.png
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Agreement with Nexgen Medical for Distribution of Excellagen® Wound Conforming Matrix in Malaysia
May 03, 2021 09:00 ET | Generex Biotechnology Corp.
MIRAMAR, Fla., May 03, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) subsidiary Olaregen Therapeutix today announced that the company has executed a...
LogoEmail.png
Generex Provides Update on its Ii-Key COVID-19 Complete Vaccine Program: Advancing Global Development
April 27, 2021 08:30 ET | Generex Biotechnology Corp.
Generex receives $2 million payment from Chinese partners to provide research results, data, and necessary documents to support an IND submission to the Chinese National Medical Products...
LogoEmail.png
NuGenerex Immuno-Oncology Submits Protocol, Data, and Manufacturing Information to FDA in Advance of the IND Submission
April 12, 2021 08:00 ET | Generex Biotechnology Corp.
Response to Pre-IND CommentsPre-clinical and ex-vivo resultsGMP ManufacturingAdjuvant dataRevised protocol as per FDA recommendations MIRAMAR, Fla., April 12, 2021 (GLOBE NEWSWIRE) -- NuGenerex...
LogoEmail.png
Last Chance for Children is Proud to Announce its Partnership with Generex Biotechnology & NuGenerex Immuno-Oncology to SAFELY and EFFECTIVELY Vaccinate Children and Pregnant Women NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) -- Last Chance for Children’s (LCFC) Mission is to help save children’s lives anywhere in the world. Due to the COVID-19 pandemic we are now focusing our...
LogoEmail.png
Generex Biotechnology Announces Shareholder Conference Call Scheduled for Thursday May 6, 2021
March 31, 2021 11:03 ET | Generex Biotechnology Corp.
MIRAMAR, Fla., March 31, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB: GNBT) (“Generex or the “Company”), an innovative and integrated healthcare holding company with end-to-end...